Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Mapp_Biopharmaceutical> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Mapp_Biopharmaceutical abstract "Mapp Biopharmaceutical is an American pharmaceutical company based in San Diego, California. It is responsible for the research and development of ZMapp, a drug which is still under development, comprising three humanized monoclonal antibodies as a treatment for Ebola virus disease. The drug was first tested in humans during the 2014 West Africa Ebola virus outbreak. The ZMapp drug is a result of the collaboration between Mapp Biopharmaceutical, LeafBio (the commercial arm of Mapp Biopharmaceutical), Defyrus Inc. (Toronto), the U.S. government and the Public Health Agency of Canada. The antibody work came out of research projects funded by Defense Advanced Research Projects Agency(DARPA) more than a decade ago, and years of funding by the Public Health Agency of Canada. ZMapp is manufactured in the tobacco plant Nicotiana benthamiana in the bioproduction process known as "pharming" by Kentucky BioProcessing, a subsidiary of Reynolds American.".
- Mapp_Biopharmaceutical product Biopharmaceutical.
- Mapp_Biopharmaceutical wikiPageExternalLink www.mappbio.com.
- Mapp_Biopharmaceutical wikiPageExternalLink larry-zeitlin-kevin-whaley-mapp-ebola-serum.
- Mapp_Biopharmaceutical wikiPageID "43613255".
- Mapp_Biopharmaceutical wikiPageLength "4716".
- Mapp_Biopharmaceutical wikiPageOutDegree "19".
- Mapp_Biopharmaceutical wikiPageRevisionID "662756610".
- Mapp_Biopharmaceutical wikiPageWikiLink 2014_West_Africa_Ebola_virus_outbreak.
- Mapp_Biopharmaceutical wikiPageWikiLink Biopharmaceutical.
- Mapp_Biopharmaceutical wikiPageWikiLink Bioproduction.
- Mapp_Biopharmaceutical wikiPageWikiLink California.
- Mapp_Biopharmaceutical wikiPageWikiLink Category:Biotechnology.
- Mapp_Biopharmaceutical wikiPageWikiLink Category:Companies_based_in_San_Diego,_California.
- Mapp_Biopharmaceutical wikiPageWikiLink Category:Pharmaceutical_companies_of_the_United_States.
- Mapp_Biopharmaceutical wikiPageWikiLink DARPA.
- Mapp_Biopharmaceutical wikiPageWikiLink Ebola_virus_disease.
- Mapp_Biopharmaceutical wikiPageWikiLink Ebola_virus_epidemic_in_West_Africa.
- Mapp_Biopharmaceutical wikiPageWikiLink Humanized_antibody.
- Mapp_Biopharmaceutical wikiPageWikiLink Monoclonal_antibody.
- Mapp_Biopharmaceutical wikiPageWikiLink Nicotiana_benthamiana.
- Mapp_Biopharmaceutical wikiPageWikiLink Pharmaceutical_industry.
- Mapp_Biopharmaceutical wikiPageWikiLink Pharming_(genetics).
- Mapp_Biopharmaceutical wikiPageWikiLink Public_Health_Agency_of_Canada.
- Mapp_Biopharmaceutical wikiPageWikiLink Reynolds_American.
- Mapp_Biopharmaceutical wikiPageWikiLink San_Diego.
- Mapp_Biopharmaceutical wikiPageWikiLink Toronto.
- Mapp_Biopharmaceutical wikiPageWikiLink ZMapp.
- Mapp_Biopharmaceutical wikiPageWikiLinkText "Mapp Biopharmaceutical".
- Mapp_Biopharmaceutical hasPhotoCollection Mapp_Biopharmaceutical.
- Mapp_Biopharmaceutical keyPeople "President: Larry Zeitlin, CEO: Kevin Whaley".
- Mapp_Biopharmaceutical products "Biopharmaceuticals".
- Mapp_Biopharmaceutical subsid "LeafBio".
- Mapp_Biopharmaceutical wikiPageUsesTemplate Template:Infobox_company.
- Mapp_Biopharmaceutical wikiPageUsesTemplate Template:Reflist.
- Mapp_Biopharmaceutical subject Category:Biotechnology.
- Mapp_Biopharmaceutical subject Category:Companies_based_in_San_Diego,_California.
- Mapp_Biopharmaceutical subject Category:Pharmaceutical_companies_of_the_United_States.
- Mapp_Biopharmaceutical hypernym Company.
- Mapp_Biopharmaceutical type Agent.
- Mapp_Biopharmaceutical type Company.
- Mapp_Biopharmaceutical type Organisation.
- Mapp_Biopharmaceutical type Organization.
- Mapp_Biopharmaceutical type Agent.
- Mapp_Biopharmaceutical type SocialPerson.
- Mapp_Biopharmaceutical type Thing.
- Mapp_Biopharmaceutical type Q43229.
- Mapp_Biopharmaceutical comment "Mapp Biopharmaceutical is an American pharmaceutical company based in San Diego, California. It is responsible for the research and development of ZMapp, a drug which is still under development, comprising three humanized monoclonal antibodies as a treatment for Ebola virus disease. The drug was first tested in humans during the 2014 West Africa Ebola virus outbreak.".
- Mapp_Biopharmaceutical label "Mapp Biopharmaceutical".
- Mapp_Biopharmaceutical sameAs Mapp_Biopharmaceutical.
- Mapp_Biopharmaceutical sameAs m.011qdkpm.
- Mapp_Biopharmaceutical sameAs Q17578037.
- Mapp_Biopharmaceutical sameAs Q17578037.
- Mapp_Biopharmaceutical wasDerivedFrom Mapp_Biopharmaceutical?oldid=662756610.
- Mapp_Biopharmaceutical isPrimaryTopicOf Mapp_Biopharmaceutical.